Becton, Dickinson and Co. | BDX - Equity Capital And Reserves

Stock Price
158.02
Daily Change
-3.62 -2.24%
Monthly
-13.40%
Yearly
-31.83%
Q1 Forecast
154.55

Becton, Dickinson and Co. reported $25.28B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.13B 1.3B Dec/2025
Agilent USD 6.91B 167M Dec/2025
Align Technology USD 3.96B 44.68M Sep/2025
AngioDynamics USD 185.87M 898K Feb/2025
Avanos Medical USD 778.2M 200K Dec/2025
Baxter International USD 6.13B 1.11B Dec/2025
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Bio-Rad Laboratories USD 7.45B 716.8M Dec/2025
Boston Scientific USD 24.23B 1.58B Dec/2025
Cooper Companies USD 8.36B 124.7M Dec/2025
Danaher USD 52.53B 1.46B Dec/2025
Dentsply International USD 1.34B 139M Dec/2025
Dexcom USD 2.75B 19.9M Dec/2025
Edwards Lifesciences USD 10.2B 340.3M Sep/2025
Exact Sciences USD 2.4B 100.37M Dec/2025
Globus Medical USD 4.57B 174.42M Dec/2025
Hologic USD 5.25B 197.2M Dec/2025
Insulet USD 1.52B 131.1M Dec/2025
Integra LifeSciences USD 1.04B 5.89M Dec/2025
Intuitive Surgical USD 17.82B 894.3M Dec/2025
J&J USD 78.47B 0 Sep/2025
Masimo USD 721.2M 88.8M Dec/2025
Medtronic USD 48.86B 964M Sep/2025
Solventum Corp USD 5.05B 63M Dec/2025
Stryker USD 21.78B 594M Sep/2025
Tandem Diabetes Care USD 155.17M 22.2M Dec/2025
Teleflex USD 3.12B 697.09M Dec/2025
Terumo JPY 1.52T 84.79B Dec/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Zimmer Biomet Holdings USD 12.7B 68.3M Dec/2025